House Lawmaker Raises New Concerns Over FDA's Ultra-Fast Drug Review Program

Back to news list

Source: MedPage Today

Original: https://www.medpagetoday.com/publichealthpolicy/fdageneral/119721...

Published: Tue, 03 Feb 2026 16:42:34 -0500

I cannot create a summary of a particular article from MedPage Today because you have not provided me with the full text of the article. The search results I received include information about FDA Commissioner Marty Makary's National Priority Voucher (NPV) program, but not the specific article you listed. Based on available sources, I can confirm that Democratic lawmakers and experts are indeed expressing concern about this ultra-rapid drug review program[1][5]. Concerns mainly concern whether decisions are based on science or political influences, and whether ethical standards are followed[5]. If you could provide me with the full text of the article from MedPage Today that you mentioned, I would be happy to create an accurate and factual summary in Slovak according to your requirements.